MDT241018C89000
- 3.17
- +2.01+173.28%
Medtronic Newsroom
Does Medtronic Plc's (NYSE:MDT) Weak Fundamentals Mean That The Market Could Correct Its Share Price?
Form 144 | Medtronic(MDT.US) Insider Proposes to Sell 4.48 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Oct 18, $Medtronic(MDT.US)$ Insider PARKHILL KAREN L intends to sell 48,825 shares of its common stock on Oct 18, with a total market value of approximately $4.48 million.
Shares of Surgical Tool and Medical Instrument Stocks Are Trading Higher in Sympathy With Intuitive Surgical, Which Gained on Strong Q3 Earnings.
Medtronic Stock Hits 52-week High at $91.53 Amid Robust Gains
Oppenheimer Buy-rated Ideas: BSX, MDT, and One Hold: CYTK
Form 144 | Medtronic(MDT.US) Insider Proposes to Sell 4.96 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Oct 17, $Medtronic(MDT.US)$ Insider PARKHILL KAREN L intends to sell 55,179 shares of its common stock on Oct 17, with a total market value of approximately $4.96 million.
Apple Chief People Officer to Leave Company After Two-year Stint: Report
Least Shorted S&P 500 Stocks in September
Trauma Fixation Device Research Report and Company Analysis 2024-2032 Featuring Zimmer Biomet, Orthofix Medical, B. Braun Meslungen, Stryker, Medtronic, Smith & Nephew, Integra LifeSciences, & Otto - ResearchAndMarkets.com
Baird Maintains Medtronic(MDT.US) With Hold Rating, Raises Target Price to $96
France Diabetes Devices Market Report (2024-2032) With Analysis by Type, Distribution Channel and Company - BD, Medtronic, Tandem Diabetes Care, Novo Nordisk, Roche, Abbott Labs, Eli Lilly, Ypsomed, Dexcom
After eight weeks of selling off, the hedge fund bought back US stocks, achieving the fastest speed since 2021.
The US stock market is currently experiencing active buying and market growth, but the market's high valuation is a concerning issue that may trigger future adjustments.
Truist Financial Maintains Medtronic(MDT.US) With Hold Rating, Raises Target Price to $93
Medtronic Analyst Ratings
FDA Approves Medtronic's Affera System for VT Treatment Study
Truist Raises Price Target on Medtronic to $93 From $90, Maintains Hold Rating
Does Medtronic (NYSE:MDT) Have A Healthy Balance Sheet?
U.S. Surgical Instrument Tracking Systems Market Trends Analysis Report 2024-2030 With Company Profiles of 10+ Leading Players Including BD, Medtronic, B. Braun, Olympus, 3M, and Stryker
Morgan Stanley Maintains Medtronic(MDT.US) With Buy Rating, Maintains Target Price $98
Buy Rating on Medtronic: Stable Demand, Margin Improvement, and Strategic Positioning Fuel Optimistic Outlook